Skip to main content

Advertisement

Log in

Universal risk factors for multifactorial diseases

LifeLines: a three-generation population-based study

  • NEW STUDY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

The risk for multifactorial diseases is determined by risk factors that frequently apply across disorders (universal risk factors). To investigate unresolved issues on etiology of and individual’s susceptibility to multifactorial diseases, research focus should shift from single determinant-outcome relations to effect modification of universal risk factors. We present a model to investigate universal risk factors of multifactorial diseases, based on a single risk factor, a single outcome measure, and several effect modifiers. Outcome measures can be disease overriding, such as clustering of disease, frailty and quality of life. “Life course epidemiology” can be considered as a specific application of the proposed model, since risk factors and effect modifiers of multifactorial diseases typically have a chronic aspect. Risk factors are categorized into genetic, environmental, or complex factors, the latter resulting from interactions between (multiple) genetic and environmental factors (an example of a complex factor is overweight). The proposed research model of multifactorial diseases assumes that determinant-outcome relations differ between individuals because of modifiers, which can be divided into three categories. First, risk-factor modifiers that determine the effect of the determinant (such as factors that modify gene-expression in case of a genetic determinant). Second, outcome modifiers that determine the expression of the studied outcome (such as medication use). Third, generic modifiers that determine the susceptibility for multifactorial diseases (such as age). A study to assess disease risk during life requires phenotype and outcome measurements in multiple generations with a long-term follow up. Multiple generations will also enable to separate genetic and environmental factors. Traditionally, representative individuals (probands) and their first-degree relatives have been included in this type of research. We put forward that a three-generation design is the optimal approach to investigate multifactorial diseases. This design has statistical advantages (precision, multiple-informants, separation of non-genetic and genetic familial transmission, direct haplotype assessment, quantify genetic effects), enables unique possibilities to study social characteristics (socioeconomic mobility, partner preferences, between-generation similarities), and offers practical benefits (efficiency, lower non-response). LifeLines is a study based on these concepts. It will be carried out in a representative sample of 165,000 participants from the northern provinces of the Netherlands. LifeLines will contribute to the understanding of how universal risk factors are modified to influence the individual susceptibility to multifactorial diseases, not only at one stage of life but cumulatively over time: the lifeline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organisation. World Health Report 2002; Reducing risk, promoting healthy life. Geneva: World Health Organisation; 2002.

  2. De Stavola BL, Nitsch D, dos Santos Silva I, et al. Statistical issues in life course epidemiology. Am J Epidemiol. 2006;163:84–96.

    Article  PubMed  Google Scholar 

  3. Barker DJ, Eriksson JG, Forsen T, et al. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31:1235–39.

    Article  PubMed  CAS  Google Scholar 

  4. Zaher C, Halbert R, Dubois R, et al. Smoking-related diseases: the importance of COPD. Int J Tuberc Lung Dis. 2004;8:1423–8.

    PubMed  CAS  Google Scholar 

  5. Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull. 1996;52:58–73.

    PubMed  CAS  Google Scholar 

  6. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005;95 Suppl 1:S144–50.

    Article  PubMed  Google Scholar 

  7. Kelada SN, Eaton DL, Wang SS, et al. The role of genetic polymorphisms in environmental health. Environ Health Perspect. 2003;111:1055–64.

    PubMed  CAS  Google Scholar 

  8. Aneshensel CS, Frerichs RR, Huba GJ. Depression and physical illness: a multiwave, nonrecursive causal model. J Health Soc Behav. 1984;25:350–71.

    Article  PubMed  CAS  Google Scholar 

  9. Hotopf M, Mayou R, Wadsworth M, et al. Temporal relationships between physical symptoms and psychiatric disorder - Results from a national birth cohort. Br J Psychiatry 1998;173:255–61.

    PubMed  CAS  Google Scholar 

  10. Stansfeld SA, Smith GD, Marmot M. Association between physical and psychological morbidity in the Whitehall II Study. J Psychosom Res. 1993;37:227–38.

    Article  PubMed  CAS  Google Scholar 

  11. Cynader MS. Mechanisms of brain-development and their role in health and well-being. Daedalus 1994;123:155–65.

    Google Scholar 

  12. Plagemann A. Fetal programming and functional teratogenesis: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks. J Perinat Med. 2004;32:297–305.

    Article  PubMed  CAS  Google Scholar 

  13. Power C, Hertzman C. Social and biological pathways linking early life and adult disease. Br Med Bull. 1997;53:210–21.

    PubMed  CAS  Google Scholar 

  14. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, et al. ACE polymorphisms. Circ Res. 2006;98:1123–33.

    Article  PubMed  CAS  Google Scholar 

  15. Neil JR, Galliher AJ, Schiemann WP. TGF-beta in cancer and other diseases. Future Oncol. 2006;2:185–9.

    Article  PubMed  CAS  Google Scholar 

  16. Russo C, Polosa R. TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clin Sci (Lond). 2005;109:135–42.

    Article  CAS  Google Scholar 

  17. Pereira MA, Kartashov AI, Ebbeling CB, et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 2005;365:36–42.

    Article  PubMed  Google Scholar 

  18. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.

    Article  PubMed  Google Scholar 

  19. Tennant C. Life events, stress and depression: a review of recent findings. Aust N Z J Psychiatry 2002;36:173–82.

    Article  PubMed  Google Scholar 

  20. Ormel J, Oldehinkel AJ, Brilman EI. The interplay and etiological continuity of neuroticism, difficulties, and life events in the etiology of major and subsyndromal, first and recurrent depressive episodes in later life. Am J Psychiatry 2001;158:885–91.

    PubMed  CAS  Google Scholar 

  21. Lichtenstein P, Pedersen NL. Does genetic variance for cognitive abilities account for genetic variance in educational achievement and occupational status? A study of twins reared apart and twins reared together. Soc Biol. 1997;44:77–90.

    PubMed  CAS  Google Scholar 

  22. Kessler RC, Foster CL, Saunders WB, et al. Social consequences of psychiatric disorders, I: educational attainment. Am J Psychiatry 1995;152:1026–32.

    PubMed  CAS  Google Scholar 

  23. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102:10604–9.

    Article  PubMed  CAS  Google Scholar 

  24. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583–9.

    Article  PubMed  CAS  Google Scholar 

  25. Feinstein AR. The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23:455–68.

    Article  Google Scholar 

  26. van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity; what’s in a name? A review of the literature. Eur J Gen Pract. 1996;2:65–70.

    Article  Google Scholar 

  27. van den Akker M, Buntinx F, Metsemakers JFM, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367–75.

    Article  PubMed  Google Scholar 

  28. Guralnik JM, Kaplan GA. Predictors of healthy aging: prospective evidence from the Alameda County study. Am J Public Health 1989;79:703–8.

    Article  PubMed  CAS  Google Scholar 

  29. Von KM, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203.

    Article  Google Scholar 

  30. Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255–63.

    PubMed  Google Scholar 

  31. Ormel J, Vonkorff M, Ustun TB, et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994;272:1741–8.

    Article  PubMed  CAS  Google Scholar 

  32. Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf) 2005;27:281–91.

    Article  Google Scholar 

  33. Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004;52:625–34.

    Article  PubMed  Google Scholar 

  34. Rockwood K, Howlett SE, MacKnight C, et al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci. 2004;59:1310–7.

    PubMed  Google Scholar 

  35. Boxenbaum H. Gompertz mortality analysis: aging, longevity hormesis and toxicity. Arch Gerontol Geriatr. 1991;13:125–37.

    Article  PubMed  CAS  Google Scholar 

  36. Quantitative Genetic Theory. In: Plomin R, De Fries JC, McClearn GE, et al., editors. Behavioral genetics. A primer.4th ed. New York: Freeman & co; 2000. p. 207–254.

  37. Luo S, Klohnen EC. Assortative mating and marital quality in newlyweds: a couple-centered approach. J Pers Soc Psychol. 2005;88:304–26.

    Article  PubMed  Google Scholar 

  38. Collins FS. The case for a US prospective cohort study of genes and environment. Nature 2004;429:475–7.

    Article  PubMed  CAS  Google Scholar 

  39. Barbour V. UK Biobank: a project in search of a protocol? Lancet 2003;361:1734–8.

    Article  PubMed  Google Scholar 

  40. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138–47.

    Article  PubMed  CAS  Google Scholar 

  41. http://www.p3gconsortium.org. 2006. Accessed Dec 2007.

  42. http://www.genome.gov/13014436. 2006. Accessed Dec 2007.

Download references

Acknowledgements

We thank Prof. J.A. Neeleman for his valuable contribution to the development of some ideas presented in this paper. RS was primarily responsible for designing, initiating, drafting of the manuscript. JR participated in the writing of the paper. All authors participated in essential discussions on the concepts and critically reviewed the manuscript.

Funding

The LifeLines project is funded by several public sources (University Medical Center Groningen, University and city of Groningen, Northern Dutch region) who were not involved in the preparation of this paper.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald P. Stolk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stolk, R.P., Rosmalen, J.G.M., Postma, D.S. et al. Universal risk factors for multifactorial diseases. Eur J Epidemiol 23, 67–74 (2008). https://doi.org/10.1007/s10654-007-9204-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-007-9204-4

Keywords

Navigation